U.S. Wound Care Market Size To Hit USD 24.05 Bn By 2033
The U.S. wound care market size was estimated at USD 14.61 billion in 2023 and is projected to hit around USD 24.05 billion by 2033, growing at a CAGR of 5.11% during the forecast period from 2024 to 2033.
Key Takeaways:
U.S. Wound Care Market Overview
The U.S. Wound Care Market plays a pivotal role in providing advanced solutions and products for the effective treatment and management of wounds. This comprehensive overview delves into the key facets of the U.S. Wound Care Market, shedding light on its current status, growth drivers, challenges, and future trajectories.
U.S. Wound Care Market Growth
The growth of the U.S. Wound Care Market is underpinned by several key factors that collectively contribute to its dynamic expansion. One of the primary drivers is the aging population coupled with the increasing prevalence of chronic diseases. As the demographic landscape shifts towards an older population, the demand for advanced wound care solutions rises, addressing the unique challenges posed by chronic conditions. Technological advancements in wound care products play a pivotal role in market growth, with innovations such as advanced dressings and therapeutic devices enhancing the efficacy of treatments and improving overall patient outcomes. Moreover, the escalating incidence of diabetes, often associated with chronic wounds, amplifies the demand for specialized wound care solutions tailored to effectively manage diabetic wounds. These growth factors collectively propel the U.S. Wound Care Market forward, reflecting the market's adaptability and responsiveness to evolving healthcare needs.
U.S. Wound Care Market Report Scope
| Report Attribute | Details |
| Market Size in 2024 | USD 15.36 Billion |
| Market Size by 2033 | USD 24.05 Billion |
| Growth Rate From 2024 to 2033 | CAGR of 5.11% |
| Base Year | 2023 |
| Forecast Period | 2024 to 2033 |
| Segments Covered | Product, application, end-use, mode of purchase, distribution channel |
| Market Analysis (Terms Used) | Value (US$ Million/Billion) or (Volume/Units) |
| Report Coverage | Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
| Key Companies Profiled | Smith & Nephew PLC; Mölnlycke Health Care AB ; ConvaTec Group PLC; Baxter International; URGO Medical; Coloplast Corp.; Medtronic; 3M; Derma Sciences (Integra LifeSciences); Medline Industries, Inc.; Ethicon (Johnson & Johnson); B. Braun SE; Cardinal Health, Inc.; Organogenesis Inc; MIMEDX Group, Inc. |
U.S. Wound Care Market Dynamics
Drivers
Technological Advancements in Wound Care Products:
Ongoing innovations in wound care products, including advanced dressings and therapeutic devices, are key drivers for market growth. Technological advancements enhance the efficacy of treatments, offering more efficient and patient-friendly solutions for wound management.
Increasing Incidence of Diabetes:
The rising prevalence of diabetes is closely associated with chronic wounds, such as diabetic foot ulcers. This heightened incidence amplifies the demand for specialized wound care solutions, emphasizing the need for targeted products and treatment approaches in the market.
Restraints
Cost Constraints:
The cost associated with advanced wound care solutions poses a significant restraint. Access to high-quality wound care products may be limited due to financial considerations, impacting the adoption of these solutions and potentially hindering optimal patient care
Market Fragmentation:
The U.S. Wound Care Market is characterized by the presence of numerous products and providers, leading to market fragmentation. This fragmentation can result in challenges related to standardization, making it more complex for healthcare professionals to choose and implement the most effective wound care solutions.
Addressing these restraints requires a delicate balance between providing cost-effective solutions, navigating regulatory complexities, and streamlining market dynamics for more efficient and standardized practices in the U.S. Wound Care Market.
Opportunities
Technological Advancements:
The continual advancements in technology open doors for new opportunities within the market. The integration of digital solutions, smart dressings, and telemedicine in wound management creates avenues for more efficient and patient-centric care approaches.
Focus on Sustainability:
The growing emphasis on sustainability in healthcare practices presents an opportunity for the development of eco-friendly wound care products. Companies exploring environmentally responsible materials and manufacturing processes can align with this trend and cater to an environmentally conscious market.
Challenges
Intense Competition:
The competitive landscape within the U.S. Wound Care Market is intense. Numerous companies vie for market share, leading to challenges in differentiation and market positioning. This competitive environment may pose hurdles for newer entrants and smaller players.
Integration of Technological Innovations:
While technological advancements offer opportunities, their integration also presents challenges. Implementing and adopting new technologies in wound care practices require significant investments, training, and adjustments to existing workflows, posing challenges for some healthcare institutions.
Segments Insights:
Mode of Purchase Insights
Based on the mode of purchase, the U.S. wound care industry is segmented into prescribed and non-prescribed. The prescribed segment dominated the market with a market share of 63% in 2023. Also, prescribed segment is expected to grow at the highest compound annual growth rate (CAGR) of 4.93% in 2024 to 2033.
Prescribed wound care medications require a prescription from a licensed medical practitioner as they are harmful if not monitored. Moreover, people are more inclined toward prescribed wound care products as Medicare covers around 80% of the cost of medically necessary wound care supplies and surgical dressings. This encourages people to visit physicians and receive prescribed wound care medication. These factors are propelling the segment's growth.
Distribution Channel Insights
Based on distribution channels, the market is segmented into institutional sales and retail sales. The institutional sales segment dominated the market with a market share of 82.06% in 2023. The majority of the products for advanced wound care are directly distributed across various settings, such as hospitals & other healthcare facilities. Institutional sales majorly comprise distributors and manufacturers. Hospitals, clinics, wound care centers, and other healthcare facilities, such as nursing homes, long-term care facilities, diagnostic laboratories, & birth centers, usually have long-term contracts and tie-ups with distributors & manufacturers. Key players are adopting long-term contracts with end users as a strategy to expand their reach and strengthen their foothold in the market. These above-mentioned factors are propelling the segment's growth.
The retail sales segment is expected to grow at the highest compound annual growth rate (CAGR) of 4.49% in 2024 to 2033. Retail sales mainly comprises retail pharmacy stores, e-commerce, etc. Customers benefit from pharmacies as they are available in large numbers. They offer various delivery concepts and usually provide good service. Prescription and non-prescription wound care products are typically purchased at retail pharmacy stores by customers. However, they may lack enough product knowledge, and not all products are available in all pharmacies. These factors are anticipated to propel market growth over the forecast period.
Product Insights
Based on the product, the market is segmented into advanced wound dressing, surgical wound care, traditional wound care, and wound therapy devices. The advanced wound dressing segment dominated the market with the highest market share of around 34.94% in 2023 and is also expected to grow at the highest compound annual growth rate (CAGR) of 4.37% from 2024 to 2034. Advanced wound dressing is mainly used to treat chronic and nonhealing wounds. Some products of advanced wound dressings are equipped with antimicrobial agents, such as honey & silver, for rapid wound healing and preventing further infections. The limitations of traditional wound dressings have propelled the growth of this market. Moreover, increasing cases of diabetes are also expected to impel segment growth over the forecast period. For instance, as per the report of the Centers for Disease Control and Prevention (CDC) last reviewed in April 2023, 37.3 million Americans have diabetes, whereas 96 million American adults are expected to have prediabetes.
Application Insights
Based on application, the market is segmented into chronic wounds and acute wounds. The chronic wounds segment dominated the market with a market share of 60.13% in 2023. This growth can be attributed to factors such as the increase in the number of chronic wounds, such as diabetic foot ulcers, venous leg ulcers, and pressure ulcers, which are expected to drive the demand for wound care products. Moreover, the increasing incidence of diabetes and diabetic foot ulcers is a major factor driving the segment's growth. For instance, according to ScienceDirect, diabetic foot ulcers may affect more than 25% of the diabetic population and may lead to the amputation of the foot in 20% of patients.
The acute wounds segment is expected to grow at the highest compound annual growth rate (CAGR) of 4.23% in 2024 to 2033. The rising number of Surgical-site Infections (SSIs) and the Increasing cases of burn injuries is the major driving factors for the segment growth. Furthermore, the rising incidence of trauma is contributing to segment growth. For instance, as per a study by ResearchGate, in 2020, around 6.6% of deaths occurred every year due to trauma. Hence, an increase in the incidence of traumatic wounds and a rise in the prevalence of SSI are among the factors anticipated to propel market growth over the forecast period.
End-use Insights
Based on end-use, the market is segmented into hospitals, outpatient facilities, home care, and research & manufacturing. The hospitals segment held the largest share of 45.17% in the market in 2023. Hospitals use wound care products to treat a variety of wounds, including surgical wounds, burns, pressure ulcers, and diabetic foot ulcers. The demand for advanced wound care products in hospitals is driven by factors such as the growing incidence of chronic wounds, an increase in the number of surgeries, and a rise in the aging population. Surgical wound care dressings and Negative Pressure Wound Therapy (NPWT) are predominantly suitable for hospital use and are not feasible for home care. Thus, with an increasing number of hospitals and hospitalization cases, the segment is expected to have significant growth over the forecast period.
The home care segment is expected to grow at the highest compound annual growth rate (CAGR) of 4.82% from 2024 to 2033. An increase in the aging population and technological advancement in wound care is expected to drive the segment growth. The advanced wound care products industry has seen significant technological advancements, such as the development of smart dressings that can monitor and manage wounds. These technologies are increasingly being adopted in home healthcare settings, allowing for better wound management and reducing the need for frequent visits to healthcare facilities. Furthermore, home healthcare services are often more cost-effective than inpatient care, making them an attractive option for patients, insurers, and healthcare providers. These factors are expected to boost the segment growth over the forecast period.
Some of the prominent players in the U.S. Wound Care Market include:
Segments Covered in the Report
This report forecasts revenue growth at country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Nova one advisor, Inc. has segmented the U.S. Wound Care market.
By Product
By Application
By End-use
Mode of Purchase
By Distribution Channel
Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Product
1.1.2. Application
1.1.3. End-use
1.1.4. Mode of purchase
1.1.5. Distribution channel
1.1.6. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. nova one advisor internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.3.5.1. Data for primary interviews in North America
1.3.5.2. Data for primary interviews in Europe
1.3.5.3. Data for primary interviews in Asia Pacific
1.3.5.4. Data for primary interviews in Latin America
1.3.5.5. Data for Primary interviews in MEA
1.4. Information or Data Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.6.1. Commodity flow analysis (Model 1)
1.6.1.1. Approach 1: Commodity flow approach
1.6.2. Volume price analysis (Model 2)
1.6.2.1. Approach 2: Volume price analysis
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
1.9.1. Objective 1
1.9.2. Objective 2
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Product outlook
2.2.2. Application outlook
2.2.3. End-use outlook
2.2.4. Mode of purchase outlook
2.2.5. Distribution channel outlook
2.3. Competitive Insights
Chapter 3. U.S. Wound Care Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.1.1. Increasing prevalence of chronic diseases and conditions affecting wound healing capabilities
3.2.1.2. Introduction of innovative and advanced wound products
3.2.1.3. Rising geriatric population
3.2.1.4. Increasing number of ambulatory surgical centers (ASCs)
3.2.1.5. Increasing number of accidents
3.2.1.6. Steep rise in the number of hospitals & urgent care centers and an increase in hospital admissions
3.2.1.7. Improvements in public and private hospital infrastructure
3.2.2. Market restraint analysis
3.2.2.1. Stringent manufacturing policies
3.2.2.2. High cost of advanced wound care products and chronic wound treatments
3.2.3. Market opportunity analysis
3.3. U.S. Wound Care Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.1.1. Supplier power
3.3.1.2. Buyer power
3.3.1.3. Substitution threat
3.3.1.4. Threat of new entrant
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Technological landscape
3.3.2.3. Economic landscape
3.3.3. Covid-19 Impact Analysis
Chapter 4. U.S. Wound Care Market: Product Estimates & Trend Analysis
4.1. Definitions and Scope
4.1.1. Advanced wound dressing
4.1.2. Surgical wound care
4.1.3. Traditional wound care
4.1.4. Wound therapy devices
4.2. Product Market Share, 2021 to 2033
4.3. Segment Dashboard
4.4. U.S. Wound Care Market by Product Outlook
4.5. Market Size & Forecasts and Trend Analyses, 2023 to 2030 for the following
4.5.1. Advanced wound dressing
4.5.1.1. Advanced wound dressing market estimates and forecast 2021 to 2033
4.5.1.2. Foam dressings
4.5.1.2.1. Foam dressings market estimates and forecast 2021 to 2033
4.5.1.3. Hydrocolloid dressings
4.5.1.3.1. Hydrocolloid dressings market estimates and forecast 2021 to 2033
4.5.1.4. Film dressings
4.5.1.4.1. Film dressings market estimates and forecast 2021 to 2033
4.5.1.5. Alginate dressings
4.5.1.5.1. Alginate dressings market estimates and forecast 2021 to 2033
4.5.1.6. Hydrogel dressings
4.5.1.6.1. Hydrogel dressings market estimates and forecast 2021 to 2033
4.5.1.7. Collagen dressings
4.5.1.7.1. Collagen dressings market estimates and forecast 2021 to 2033
4.5.1.8. Other advanced dressings
4.5.1.8.1. Other advanced dressings market estimates and forecast 2021 to 2033
4.5.2. Surgical wound care
4.5.2.1. Surgical wound care market estimates and forecast 2021 to 2033
4.5.2.2. Sutures & staples
4.5.2.2.1. Sutures & staples market estimates and forecast 2021 to 2033
4.5.2.3. Tissue adhesives & sealants
4.5.2.3.1. Tissue adhesives & sealants market estimates and forecast 2021 to 2033
4.5.2.4. Anti-infective dressing
4.5.2.4.1. Anti-infective dressing market estimates and forecast 2021 to 2033
4.5.3. Traditional wound care
4.5.3.1. Traditional wound care market estimates and forecast 2021 to 2033
4.5.3.2. Medical tapes
4.5.3.2.1. Medical tapes market estimates and forecast 2021 to 2033
4.5.3.3. Cotton
4.5.3.3.1. Cotton market estimates and forecast 2021 to 2033
4.5.3.4. Bandages
4.5.3.4.1. Bandages market estimates and forecast 2021 to 2033
4.5.3.5. Gauzes
4.5.3.5.1. Gauzes market estimates and forecast 2021 to 2033
4.5.3.6. Sponges
4.5.3.6.1. Sponges market estimates and forecast 2021 to 2033
4.5.3.7. Cleansing agents
4.5.3.7.1. Cleansing agents market estimates and forecast 2021 to 2033
4.5.4. Wound therapy devices
4.5.4.1. Wound therapy devices market estimates and forecast 2021 to 2033
4.5.4.2. Negative pressure wound therapy
4.5.4.2.1. Negative pressure wound therapy market estimates and forecast 2021 to 2033
4.5.4.3. Oxygen and hyperbaric oxygen equipment
4.5.4.3.1. Oxygen and hyperbaric oxygen equipment market estimates and forecast 2021 to 2033
4.5.4.4. Electric stimulation devices
4.5.4.4.1. Electric stimulation devices market estimates and forecast 2021 to 2033
4.5.4.5. Pressure relief devices
4.5.4.5.1. Pressure relief devices market estimates and forecast 2021 to 2033
4.5.4.6. Others
4.5.4.6.1. Others market estimates and forecast 2021 to 2033
Chapter 5. U.S. Wound Care Market: Application Estimates & Trend Analysis
5.1. Definitions and Scope
5.1.1. Acute Wounds
5.1.2. Chronic Wounds
5.2. Application Market Share, 2021 to 2033
5.3. Segment Dashboard
5.4. U.S. Wound Care Market by Application Outlook
5.5. Market Size & Forecasts and Trend Analyses, 2023 to 2030 for the following
5.5.1. Acute Wounds
5.5.1.1. Acute wounds market estimates and forecast 2021 to 2033
5.5.1.2. Surgical & traumatic wounds
5.5.1.2.1. Surgical & traumatic wounds market estimates and forecast 2021 to 2033
5.5.1.3. Burns
5.5.1.3.1. Burns market estimates and forecast 2021 to 2033
5.5.2. Chronic Wounds
5.5.2.1. Chronic wounds market estimates and forecast 2021 to 2033
5.5.2.2. Diabetic foot ulcers
5.5.2.2.1. Diabetic foot ulcers market estimates and forecast 2021 to 2033
5.5.2.3. Pressure ulcers
5.5.2.3.1. Pressure ulcers market estimates and forecast 2021 to 2033
5.5.2.4. Venous leg ulcers
5.5.2.4.1. Venous leg ulcers market estimates and forecast 2021 to 2033
5.5.2.5. Others chronic wounds
5.5.2.5.1. Others chronic wounds market estimates and forecast 2021 to 2033
Chapter 6. U.S. Wound Care Devices: End-Use Estimates & Trend Analysis
6.1. Definitions and Scope
6.1.1. Hospitals
6.1.2. Outpatient facilities
6.1.3. Home care
6.1.4. Research & manufacturing
6.2. End Use Market Share, 2021 to 2033
6.3. Segment Dashboard
6.4. U.S. Wound Care Market by End-use Outlook
6.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
6.5.1. Hospitals
6.5.1.1. Hospitals market estimates and forecast 2021 to 2033
6.5.2. Outpatient facilities
6.5.2.1. Outpatient facilities centers market estimates and forecast 2021 to 2033
6.5.3. Home care
6.5.3.1. Home care market estimates and forecast 2021 to 2033
6.5.4. Research & manufacturing
6.5.4.1. Research & manufacturing market estimates and forecast 2021 to 2033
Chapter 7. U.S. Wound Care Devices: Mode of Purchase Estimates & Trend Analysis
7.1. Definitions and Scope
7.1.1. Prescribed
7.1.2. Non-prescribed (OTC)
7.2. Mode of Purchase Market Share, 2021 to 2033
7.3. Segment Dashboard
7.4. U.S. Wound Care Market by Mode of Purchase Outlook
7.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
7.5.1. Prescribed
7.5.1.1. Prescribed market estimates and forecast 2021 to 2033
7.5.2. Non-prescribed (OTC)
7.5.2.1. Non-prescribed (OTC) market estimates and forecast 2021 to 2033
Chapter 8. U.S. Wound Care Devices: Distribution Channel Estimates & Trend Analysis
8.1. Definitions and Scope
8.1.1. Institutional sales
8.1.2. Retail sales
8.2. Distribution Channel Market Share, 2021 to 2033
8.3. Segment Dashboard
8.4. U.S. Wound Care Market by Distribution Channel Outlook
8.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
8.5.1. Institutional sales
8.5.1.1. Institutional sales market estimates and forecast 2021 to 2033
8.5.2. Retail sales
8.5.2.1. Retail sales market estimates and forecast 2021 to 2033
Chapter 9. Competitive Landscape
9.1. Recent Developments & Impact Analysis, By Key Market Participants
9.2. Company/Competition Categorization
9.2.1. Innovators
9.3. Vendor Landscape
9.3.1. List of key distributors and channel partners
9.3.2. Key customers
9.3.3. Key company market share analysis, 2023
9.3.4. Smith & Nephew PLC
9.3.4.1. Company overview
9.3.4.2. Financial performance
9.3.4.3. Product benchmarking
9.3.4.4. Strategic initiatives
9.3.5. Mölnlycke Health Care AB
9.3.5.1. Company overview
9.3.5.2. Financial performance
9.3.5.3. Product benchmarking
9.3.5.4. Strategic initiatives
9.3.6. ConvaTec Group PLC
9.3.6.1. Company overview
9.3.6.2. Financial performance
9.3.6.3. Product benchmarking
9.3.6.4. Strategic initiatives
9.3.7. Baxter International
9.3.7.1. Company overview
9.3.7.2. Financial performance
9.3.7.3. Product benchmarking
9.3.7.4. Strategic initiatives
9.3.8. URGO Medical
9.3.8.1. Financial performance
9.3.8.2. Product benchmarking
9.3.8.3. Strategic initiatives
9.3.9. Coloplast Corp.
9.3.9.1. Company overview
9.3.9.2. Financial performance
9.3.9.3. Product benchmarking
9.3.9.4. Strategic initiatives
9.3.10. Medtronic
9.3.10.1. Company overview
9.3.10.2. Financial performance
9.3.10.3. Product benchmarking
9.3.10.4. Strategic initiatives
9.3.11. 3M
9.3.11.1. Company overview
9.3.11.2. Financial performance
9.3.11.3. Product benchmarking
9.3.11.4. Strategic initiatives
9.3.12. Derma Sciences (Integra LifeSciences)
9.3.12.1. Company overview
9.3.12.2. Financial performance
9.3.12.3. Product benchmarking
9.3.12.4. Strategic initiatives
9.3.13. Medline Industries, Inc.
9.3.13.1. Company overview
9.3.13.2. Financial performance
9.3.13.3. Product benchmarking
9.3.13.4. Strategic initiatives
9.3.14. 3M
9.3.14.1. Company overview
9.3.14.2. Financial performance
9.3.14.3. Product benchmarking
9.3.14.4. Strategic initiatives
9.3.15. Ethicon (Johnson & Johnson)
9.3.15.1. Company overview
9.3.15.2. Financial performance
9.3.15.3. Product benchmarking
9.3.15.4. Strategic initiatives
9.3.16. B. Braun SE
9.3.16.1. Company overview
9.3.16.2. Financial performance
9.3.16.3. Product benchmarking
9.3.16.4. Strategic initiatives
9.3.17. Cardinal Health, Inc.
9.3.17.1. Company overview
9.3.17.2. Financial performance
9.3.17.3. Product benchmarking
9.3.17.4. Strategic initiatives
9.3.18. Organogenesis Inc
9.3.18.1. Company overview
9.3.18.2. Financial performance
9.3.18.3. Product benchmarking
9.3.18.4. Strategic initiatives
9.3.19. MIMEDX Group, Inc.
9.3.19.1. Company overview
9.3.19.2. Financial performance
9.3.19.3. Product benchmarking
9.3.19.4. Strategic initiatives
Cross-segment Market Size and Analysis for
Mentioned Segments
Additional Company Profiles (Upto 5 With No Cost)
Additional Countries (Apart From Mentioned Countries)
Country/Region-specific Report
Go To Market Strategy
Region Specific Market DynamicsRegion Level Market Share Import Export AnalysisProduction AnalysisOthers